Dr. Michael Chuong, MD
Radiation Oncology (Radiation Oncology Physician)
- Medicare participating
At a glance
- Medical school
- University of South Florida College of Medicine (2008)
- Years since graduation
- 18
- In the NPI registry since
- 2008
- Medicare patients seen, 2024
- 244
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2008Medical school: University of South Florida College of Medicine
- 2008Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Radiation Oncology Physician primary
FL license ME 128028
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Boca Raton Regional Hospital Boca Raton, FL
- Baptist Hospital of Miami Miami, FL
- South Miami Hospital Miami, FL
Medical groups
- Baptist Health Medical Group Oncology LLC (204 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 244
- Services billed
- 2,920
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Calculation of radiation therapy dose | 1,131 | 49 |
| Ct guidance for insertion of radiation therapy fields | 186 | 85 |
| High precision radiation therapy planning | 117 | 38 |
| Design and construction of radiation treatment device for high precision radiation therapy | 114 | 35 |
| Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | 77 | 31 |
| Radiation treatment management, 5 treatment sessions | 55 | 25 |
| Established patient office or other outpatient visit, 20-29 minutes | 45 | 34 |
| Complex radiation therapy planning | 43 | 43 |
| Design and construction of complex radiation treatment device | 34 | 20 |
| Obtaining respiratory data needed to develop the optimal radiation treatment | 26 | 25 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Payments from drug and device companies
In 2025, 3 companies reported 14 payments worth $7,598 in total to this clinician.
| Novocure Inc. | $6,897 |
|---|---|
| Elekta Limited | $550 |
| Elekta, Inc. | $151 |
| Honoraria | $6,000 |
|---|---|
| Food and Beverage | $708 |
| Consulting Fee | $550 |
| Travel and Lodging | $340 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Novocure Inc. Sep 17, 2025 | Honoraria | $3,000 |
| Novocure Inc. Dec 18, 2025 | Honoraria | $2,250 |
| Novocure Inc. Dec 4, 2025 | Honoraria | $750 |
| Elekta Limited Dec 15, 2025 | Consulting Fee ELEKTA MEDICAL LINEAR ACCELERATOR · LINAC SOLUTIONS (LINAC) | $550 |
| Novocure Inc. Aug 9, 2025 | Travel and Lodging travel to Nashville, TX | $340 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $161,501 in research payments for these studies, mostly to the institutions running them.
- Phase 2 Trial of Ablative MRI-guided Stereotactic Body Radiation Therapy and Tumor Treating Fields for Locally Advanced Pancreas Cancer
Novocure Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.